| PRODUCT NEWS
SYNERON CANDELA
VELASHAPE II Application Body contouring, ZELTIQ® COOLSCULPTING®
Application Body contouring The CoolSculpting® procedure is the only, non-invasive procedure that uses advanced cooling technology to gently and effectively target and eliminate fat in specific areas of a patient’s body through a proprietary technology called Cryolipolysis. This procedure involves no incisions and no anesthesia and reduces the fat layer without harming the skin or other tissues. The CoolSculpting procedure can reduce unwanted fat and bulges in the flank (love handles) and abdomen. CoolSculpting is not technique dependent and requires no staff time once the patient is set up and the treatment is underway. The CoolSculpting treatment is convenient for most patients, lasting 1-3 hours. During their treatment, they can read, work on their laptop computer, listen to music or just relax. Most patients typically resume their routine activities, including returning to work and exercise regimens on the same day as the procedure. It is designed for use in a medical office specialising in aesthetic procedures.
Contact ZELTIQ ●
www.coolsculpting.com/for-physicians
cellulite reduction VelaShape II is designed for use in medical and aesthetic practices and is indicated for non-invasive body contouring and cellulite reduction. VelaShape II combines mechanical manipulation of the skin using gentle vacuum suction with or without mechanical massage. The VelaShape II device combines elōs technology-electro-optical synergy- including IR (infrared), Bi-Polar RF (radio-frequency) and mechanical tissue manipulation using pulsed vacuum and massage rollers. The combination of IR and vacuum coupled with RF technologies causes deep heating of the connective tissue including the fibrous septae. This in turn promotes an increase in collagen depositing and cellular metabolism resulting in a localized reduction in skin laxity and volume. Mechanical tissue manipulation causes an immediate increase in circulation and lymphatic drainage, both essential components for a healthy, smooth skin structure.
Contact Syneron Candela ●
www.syneron-candela.com
SCITON
CELLUSMOOTH™
Application Body contouring, cellulite reduction
Sciton, a leading manufacturer of high-quality custom, modular, multi-application medical laser and light systems for the aesthetic medical market, announces the introduction of CelluSmooth, an innovative laser module with proprietary M3
delivery of the 1319 nm laser wavelength in three distinct modes. CelluSmooth’s M3
technology technology. CelluSmooth provides
a minimally invasive treatment for cutting fibrous septae, emulsifying fat, and tightening the dermis to improve cellulite. The CelluSmooth procedure is a fast, effective and safe treatment using a proprietary M3
technology that allows the
enables physicians to treat the causes of cellulite on the thighs, buttocks, stomach and other areas of the body in a very short procedure time. CelluSmooth is available on the JOULE platform which offers multiple modules to treat many other indications. This, combined with Sciton’s 'no consumables' commitment, means physicians enjoy a maximum return on investment.
Contact Sciton ●
www.scitoncellusmooth.com prime-journal.com | June 2013 ❚
81
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84